Skip to content

Organization in Acute Atrial Fibrillation Post Open Heart Surgery

Organization in Acute Atrial Fibrillation Post Open Heart Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00614107
Acronym
A-Fib
Enrollment
75
Registered
2008-02-13
Start date
2008-01-31
Completion date
2009-01-31
Last updated
2021-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Atrial Fibrillation post open heart surgery

Brief summary

A form of irregular heart rate called, Atrial Fibrillation (AF) is a major clinical problem. It afflicts about 2 million Americans and is the single largest heart related cause of stroke. However, despite 120 years of speculation and research, the mechanisms that cause AF are poorly understood. Acute AF is also the most common irregular heart rate after open-heart surgery in patients. This is seen in as many as 30% of such patients and often results in a longer hospital stay. In this study we would like to study the pattern of atrial fibrosis (scar tissue in the heart) and an associated blood marker (a protein called pro-collagen-1) in those patients concurrently having open heart surgery.

Interventions

None listed

Sponsors

State University of New York - Upstate Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

1. 18 years of age, Male or Female 2. Able to provide consent 3. Cardiac surgery, CABG of Valve replacement or repair.

Exclusion criteria

1. If AF terminates within 1 hour of initiation. 2. If the patient undergoes electrical cardioversion and/or receives digitalis within the first hour of inclusion. 3. If the patients and/or their family or the primary caregiver choose to be excluded from the study anytime, even after the initial 24-hour period. 4. If the patient expires within 1 hour of inclusion into the study. -

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026